vaccine development

Cambridge, Massachusetts, August 27, 2026 Moderna, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved supplemental...

Lyon, France and Yongin, Republic of Korea, Aug. 26, 2026 Osivax, a clinical-stage biopharmaceutical company developing broad-spectrum influenza vaccines,...

Wilmington, Massachusetts, August 20, 2026 Charles River Laboratories International and Medigen Vaccine Biologics Corp. (MVC) have entered into a...

NEW YORK and LYON, France, August 14, 2026 Pfizer Inc. and Valneva SE announced that the European Medicines Agency...

CAMBRIDGE, Mass., Aug. 5, 2026 Moderna, Inc. has received U.S. Food and Drug Administration (FDA) approval for mFLUSIVA® (mRNA-1010),...

BERKELEY HEIGHTS, N.J., July 15, 2026 Tonix Pharmaceuticals announced the publication of new preclinical research in the Journal of...

SHANGHAI, China, July 13, 2026 Delonix Bioworks, a clinical-stage biotechnology company specializing in genetically engineered bacterial vaccines, has announced...

COPENHAGEN, Denmark, July 1, 2026 Evaxion A/S announced that it will present new preclinical data for its investigational cytomegalovirus...

DELFT, The Netherlands, June 30, 2026 AdJane, a clinical-stage vaccine platform company, has announced the publication of first-in-human Phase...

SAN DIEGO, Calif., June 20, 2026 Replicate Bioscience has secured a $3 million research grant from the Gates Foundation...